Tetsuo Tani

1.2k total citations
36 papers, 549 citations indexed

About

Tetsuo Tani is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Tetsuo Tani has authored 36 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 9 papers in Cognitive Neuroscience. Recurrent topics in Tetsuo Tani's work include Lung Cancer Treatments and Mutations (10 papers), Neurobiology of Language and Bilingualism (7 papers) and interferon and immune responses (5 papers). Tetsuo Tani is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Neurobiology of Language and Bilingualism (7 papers) and interferon and immune responses (5 papers). Tetsuo Tani collaborates with scholars based in Japan, United States and Australia. Tetsuo Tani's co-authors include Kenzo Soejima, Katsuhiko Naoki, Hiroyuki Yasuda, Kota Ishioka, Junko Hamamoto, Daisuke Arai, Tomoko Betsuyaku, Ichiro Kawada, Shigenari Nukaga and Masayoshi Miyawaki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Tetsuo Tani

35 papers receiving 538 citations

Peers

Tetsuo Tani
Maximilian Boesch Switzerland
A-R Yoon South Korea
Amy Kluge United States
Zhaoping Wu China
Imen Najjar France
Zuping Zhang China
Dawn Morelli United States
Kanika Sharma United States
Maximilian Boesch Switzerland
Tetsuo Tani
Citations per year, relative to Tetsuo Tani Tetsuo Tani (= 1×) peers Maximilian Boesch

Countries citing papers authored by Tetsuo Tani

Since Specialization
Citations

This map shows the geographic impact of Tetsuo Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Tani more than expected).

Fields of papers citing papers by Tetsuo Tani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Tani. The network helps show where Tetsuo Tani may publish in the future.

Co-authorship network of co-authors of Tetsuo Tani

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Tani. A scholar is included among the top collaborators of Tetsuo Tani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Tani. Tetsuo Tani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murayama, Takahiko, Navin R. Mahadevan, Catherine B. Meador, et al.. (2024). Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer. Cancer Research Communications. 4(9). 2399–2414. 10 indexed citations
2.
Sasaki, Nobunari, Mizuki Homme, Takahiko Murayama, et al.. (2024). RNA sensing induced by chromosome missegregation augments anti-tumor immunity. Molecular Cell. 85(4). 770–786.e7. 5 indexed citations
3.
Kitajima, Shunsuke, Fengkai Li, Nagib Ahsan, et al.. (2023). The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells. Communications Biology. 6(1). 65–65. 7 indexed citations
4.
Takahashi, Saeko, et al.. (2023). A case of disseminated intravascular coagulation following tumour lysis syndrome due to small cell carcinoma of the lung. SHILAP Revista de lepidopterología. 11(3). e01093–e01093. 2 indexed citations
5.
Tani, Tetsuo, Ichiro Nakachi, Shinnosuke Ikemura, et al.. (2021). Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer. Cancer Management and Research. Volume 13. 7497–7503. 6 indexed citations
6.
Campisi, Marco, Shriram K. Sundararaman, Sarah E. Shelton, et al.. (2020). Tumor-Derived cGAMP Regulates Activation of the Vasculature. Frontiers in Immunology. 11. 2090–2090. 48 indexed citations
7.
Yasuda, Hiroyuki, Keigo Kobayashi, Tetsuo Tani, et al.. (2019). Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with Cetuximab. Molecular Cancer Therapeutics. 18(9). 1593–1601. 3 indexed citations
8.
9.
Tani, Tetsuo, et al.. (2019). First case report of thyroid abscess caused by Helicobacter cinaedi presenting with thyroid storm. BMC Infectious Diseases. 19(1). 166–166. 11 indexed citations
10.
Yasuda, Hiroyuki, Junko Hamamoto, Keita Masuzawa, et al.. (2018). Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations. Lung Cancer. 127. 146–152. 40 indexed citations
11.
Miyawaki, Masayoshi, Hiroyuki Yasuda, Tetsuo Tani, et al.. (2016). Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer. Molecular Cancer Research. 15(1). 106–114. 58 indexed citations
12.
Tani, Tetsuo, Katsuhiko Naoki, Takanori Asakura, et al.. (2016). Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report. Molecular and Clinical Oncology. 5(4). 488–490. 5 indexed citations
13.
Tani, Tetsuo, Hiroyuki Yasuda, Junko Hamamoto, et al.. (2015). Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK -Translocated Lung Cancer Cells. Molecular Cancer Therapeutics. 15(1). 162–171. 54 indexed citations
14.
Ohgino, Keiko, Hiroyuki Yasuda, Junko Hamamoto, et al.. (2015). Abstract 4: ABT-263 is effective in a subset of non-small cell lung cancer cell lines. Cancer Research. 75(15_Supplement). 4–4. 4 indexed citations
15.
Suzuki, Takahiro, Hiroyuki Yasuda, Daisuke Arai, et al.. (2014). Multiple roles of extracellular fibroblast growth factors in lung cancer cells. International Journal of Oncology. 46(1). 423–429. 16 indexed citations
16.
Tani, Tetsuo, et al.. (2010). Stuttering after right cerebellar infarction: A case study. Journal of Fluency Disorders. 35(2). 141–145. 14 indexed citations
17.
Tani, Tetsuo, et al.. (2010). Analysis of five cases with neurogenic stuttering following brain injury in the basal ganglia. Journal of Fluency Disorders. 36(1). 1–16. 40 indexed citations
18.
Abe, Hajime, Tomoko Umeda, Taisuke Mori, et al.. (2010). Indocyanine green fluorescence imaging system for sentinel lymph node biopsy in early breast cancer patients.. Journal of Clinical Oncology. 28(15_suppl). 649–649. 7 indexed citations
19.
Tani, Tetsuo, et al.. (2002). Analysis of articulation errors and change of prosody in a case of apraxia of speech.. Shitsugoshō kenkyū. 22(4). 280–291.
20.
Sakamoto, Hironosuke, Tetsuo Sakamaki, Tetsuo Tani, et al.. (1999). “White coat effect” induced by therapist's presence during speech therapy for stroke rehabilitation: A single case study. Archives of Physical Medicine and Rehabilitation. 80(4). 470–472. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maximilian Boesch Breakdown of academic impact, for papers by A-R Yoon Breakdown of academic impact, for papers by Amy Kluge Breakdown of academic impact, for papers by Zhaoping Wu Breakdown of academic impact, for papers by Imen Najjar Breakdown of academic impact, for papers by Zuping Zhang Breakdown of academic impact, for papers by Dawn Morelli Breakdown of academic impact, for papers by Kanika Sharma
Rankless by CCL
2026